Senior Director, New Product Planning

• Lead product-focused new product planning across early- and late-stage programs, including definition and evolution of Target Product Profiles (TPPs)
• Design and oversee qualitative and quantitative market research to inform product design, indication prioritization, and differentiation strategy
• Translate customer, payer, and market insights into clear product requirements and strategic recommendations for development teams
• Partner closely with Clinical Development, Regulatory, and Medical Affairs to ensure development plans reflect real-world market needs and constraints
• Assess competitive landscapes, evolving standards of care, and emerging data to guide product positioning and lifecycle planning
• Develop product narratives that articulate clinical value, unmet need, and differentiation for internal decision-making and external stakeholders
• Support portfolio prioritization through product-level assessments, scenario analyses, and value framing
• Prepare and present product strategy updates to governance forums and senior leadership
• Establish best practices, tools, and frameworks for product planning and insight generation across the portfolio

• Bachelor’s degree in life sciences, business, marketing, or a related field
• advanced degree (MBA, PharmD, MS) preferred
• 10+ years of experience in product strategy, new product planning, marketing, or commercial insight roles within biopharmaceuticals
• Demonstrated expertise in market research methodologies, insight generation, and translating findings into product strategy
• Strong understanding of the drug development lifecycle and how product decisions influence clinical, regulatory, and commercial outcomes
• Excellent communication skills with the ability to synthesize complex information into clear, decision-oriented recommendations
• Proven ability to influence cross-functional teams without direct authority
• Strong team orientation and passion for continuous self-development
• Experience supporting development-stage or pre-launch assets, including early asset strategy and indication expansion, highly preferred
• Background in rare disease, autoimmune, cell therapy, or other specialty therapeutic areas, highly preferred
• Hands-on experience working with external vendors for market research, advisory boards, and primary research, highly preferred
• Comfort operating in a high-growth, science-driven biotechnology environment, highly preferred

health and retirement, PTO, and stock option plans